December 10, 2018 by
Dean Richard L. Page, M.D., Russell Tracy, Ph.D., and Mary Cushman, M.D., M.Sc.
What’s it like to be in the top one percent? In the world of scientific influencers, University of Vermont biomedical scientists Mary Cushman, M.D., M.Sc., Richard Page, M.D., and Russell Tracy, Ph.D., have first-hand knowledge. They are among the most Highly Cited Researchers in 2018, according to a recently-released report
compiled by Clarivate Analytics.
According to Clarivate Analytics, Highly Cited Researchers are selected for their exceptional research performance, a status determined by the publication of multiple highly-cited research articles that rank in the top one percent by citations for their field in the Web of Science – a scientific citation indexing service maintained by Clarivate Analytics. Researchers are selected for their exceptional performance in once or more of 21 fields used in the Essential Science Indicators. Field categories include Agricultural Sciences; Biology & Biochemstry; Chemistry; Clinical Medicine (Cushman and Page); Computer Science; Cross-Fields (Tracy); Economics & Business; Engineering; Environment/Ecology; Geosciences; Immunology; Materials Science; Mathematics; Microbiology; Molecular Biology & Genetics; Neuroscience & Behavior; Pharmacology & Toxicology; Physics; Plant & Animal Science; Psychiatry/Psychology; Social Sciences; and Space Science. Tracy’s category – “Cross-Field” – is new this year and identifies researchers with substantial influence across several fields during 2006-2016.
Both Cushman, a professor of medicine and pathology & laboratory medicine, and Tracy, a professor of pathology & laboratory medicine, and biochemistry, conduct research and publish as key investigators on a number of longitudinal health studies, including the Reasons for Geographic and Racial Differences in Stroke (REGARDS
), Multi-Ethnic Study of Atheroslerosis (MESA
), and Cardiovascular Health Study
, among others.
Cushman, who is also the medical director of the thrombosis and hemostasis program at the UVM Medical Center, is editor-in-chief of the newest journal of the International Society on Thrombosis and Haemostasis – Research and Practice in Thrombosis and Haemostasis
– and is on the Board of Directors of UVM Cardiovascular Research Institute (CVRI). Recently Cushman was awarded the American Heart Association’s Population Research Prize. She is an international expert on the epidemiology of coagulation, inflammation, and other vascular-related domains in relation to etiology and pathogenesis of stroke, cognitive impairment, cardiovascular diseases, and other diseases of aging and has been a recipient of continuous National Institutes of Health funding for more than 20 years.
Page, the dean of the Larner College of Medicine and a professor of medicine, has extensive research expertise in the areas of cardiac arrhythmias and sudden cardiac arrest and has published more than 200 research articles and book chapters. He has served on numerous national committees, including the American College of Cardiology/American Heart Association Guidelines Task Force and as Chair of the Circulatory Devices Panel of the U.S. Food and Drug Administration. Page, who is a Fellow of the American Heart Association and former chair of the AHA’s Council on Clinical Cardiology (CLDC), recently received the CLDC’s Distinguished Achievement Award. In addition being a Fellow of the Heart Rhythm Society, where he served as both a board member and president, Page is past-President of the Association of Professors of Cardiology and is a Councilor of the Association of Professors of Medicine.
Tracy – who was previously recognized as one of the 400 most highly influential biomedical researchers between 1996-2011 based on data obtained from Elsevier – is the recipient of several international research awards, including the 2015 Distinguished Scientist Award from the American Heart Association/American Stroke Association. He is an expert in the field of coagulation, inflammation and adaptive immune systems in cardiovascular disease (CVD), and other chronic diseases, and has made major contributions to our understanding of inflammation in atherosclerosis and as a major cause of CVD and non-CVD morbidity and mortality in “well-controlled” HIV infected individuals. He is a distinguished investigator if the CVRI, and has been consistently funded by the NIH for more than 35 years.
Cushman and Tracy lead a large research laboratory and mentor UVM graduate students in the clinical and translational science and public health programs, postdoctoral students, as well as medical students and residents and fellows in UVM Medical Center training programs.
View the Highly Cited Researchers 2018 list.